Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stabin

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Nuclear Medicine and Biology|September 3, 1999
Comparison of 225actinium chelates: tissue distribution and radiotoxicityI A Davis, K A Glowienka, R A Boll, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjectsJ P Seibyl, E Wallace, E O Smith, et al.
Radiation Research|March 12, 1999
Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cellsS J Kennel, M Stabin, J C Roeske, et al.
Annals of the ICRP|June 13, 2015
Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used SubstancesS Mattsson, L Johansson, S Leide Svegborn, et al.
European Journal of Nuclear Medicine|August 22, 2000
Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphomaG A Wiseman, C A White, M Stabin, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Nuclear Medicine and Biology|September 3, 1999
Comparison of 225actinium chelates: tissue distribution and radiotoxicityI A Davis, K A Glowienka, R A Boll, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjectsJ P Seibyl, E Wallace, E O Smith, et al.
Radiation Research|March 12, 1999
Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cellsS J Kennel, M Stabin, J C Roeske, et al.
Annals of the ICRP|June 13, 2015
Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used SubstancesS Mattsson, L Johansson, S Leide Svegborn, et al.
European Journal of Nuclear Medicine|August 22, 2000
Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphomaG A Wiseman, C A White, M Stabin, et al.
Pageof 4